trial

Efficacy of ISST in Schizophrenia

NCTId NCT02678858
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 177 (actual)
Sponsored by Heinrich-Heine University, Duesseldorf
Primary completion 2021-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
177 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2016-03
Primary completion
2021-02
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Integrated Social Cognitive and Behavioral Skills TherapyNeurocognitive Remediation Therapy

Sponsors

Heinrich-Heine University, DuesseldorfLead Sponsor
University Hospital, BonnCollaborator
University Hospital of CologneCollaborator
University Hospital TuebingenCollaborator
Zentralinstitut für Seelische Gesundheit MannheimCollaborator
University of CologneCollaborator
Rheinhessen-Fachklinik AlzeyCollaborator
Vivantes Klinikum am UrbanCollaborator

Investigators

1
Wolfgang Wölwer, Prof. Dr.Principal Investigator

Sites

6 total
Alzey, GermanyBerlin, GermanyBonn, GermanyCologne, GermanyDüsseldorf, GermanyTübingen, Germany

Facts & assertions

4 sourced
Enrollment
177
Phase
NA
Primary Completion Date
2021-02
Status
COMPLETED
relationships
The graph out of here
drug
Integrated Social Cognitive and Behavioral Skills Therapy
drug
Neurocognitive Remediation Therapy
drug
lead_sponsor
Heinrich-Heine University, Duesseldorf
company
collaborator
University Hospital, Bonn
company
University Hospital of Cologne
company
indication
Treatment Adherence and Compliance
indication
Schizophrenia
indication
Social Skills
indication
investigator
Wolfgang Wölwer, Prof. Dr.
person